News Headlines

Display #
26 Patients Dead After Replacing Controller for Abbott’s HeartMate II Blood Pumps at Home
Noted experts critically evaluate benefits of medical marijuana for treatment of epilepsy
FDA to review Opdivo for HCC indication
FDA clears Keytruda based on cancer genetics
Under U.S. Republican bill, 23 million would lose health coverage: watchdog
Aerie Rockets as Eye Drug Wows in Key Phase III Study
New MS Drug Linked to Deadly Brain Infection
FDA Advisory Committee recommends approval of Pfizer's proposed biosimilar to Epogen® / Procrit® across all indications
One in 3 high blood pressure patients failing to take medication
Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody Candidate Targeting Tau
Drug approvals bounce back in 2017
10 Biotechs Awaiting FDA Decisions in June 2017
FDA Advisory Committee Recommends Approval of Endari from Emmaus Life Sciences for the Treatment of Sickle Cell Disease
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
Alzheimer's, Parkinson's, and Huntington's diseases share common crucial feature
New data at ATS add to the body of evidence for Roche's Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)
Trimbow is the first triple combination in a single inhaler for the treatment of COPD to receive positive opinion from the CHMP in Europe
Novartis receives positive CHMP opinion for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)
AstraZeneca Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D
AstraZeneca enters agreement with Recordati for Seloken in Europe
BTG’s pulmonary embolism device work faster and at lower doses in study
Amgen Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects
Celgene’s multiple sclerosis drug succeeds in late-stage trial
FDA staff finds Puma Biotech’s cancer drug effective, shares soar
FDA approves first drug to specifically treat GCA
Severe asthma drug shows AstraZeneca promise beyond cancer
Health Care Trends Impacting Organized Provider Groups
Just one alcoholic drink a day increases breast cancer risk, exercise lowers risk
Sanofi and Regeneron announce FDA Approval of Kevzara® (sarilumab) for the treatment of moderately to severely active rheumatoid arthritis in adult patients
100 healthy years - are kids prepared?